Fri.Sep 13, 2024

article thumbnail

Get to Know Jalia Pettis: Beauty Launchpad 25 Under 50K Winner for 2024

Beauty Launchpad

Meet Jalia Pettis (@jaliadp). She is a session stylist and creative entrepreneur who freelances under her own business umbrella, 3Jay Productions.

98
article thumbnail

FDA Approves Lebrikizumab-lbkz for Moderate to Severe Atopic Dermatitis

Dermatology Times

Ebglyss is now approved for children and adults aged 12 years and older.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

MedEsthetics Reveals 2025 Editorial Themes

MedEsthetics

Are you ready for another year of medical aesthetics? Use our Media Planner to take advantage of opportunities across MedEsthetics' media universe throughout the year.

Medical 78
article thumbnail

The Weekly Roundup: September 9-13

Dermatology Times

In case you missed it, this week we had news about adverse event profiles among pediatric patients treated with JAK inhibitors, positive results from a phase 3 trial of dupilumab for chronic spontaneous urticaria, and the impact of tropical weather on patients with atopic dermatitis.

article thumbnail

MY SALON Suite Awarded Prestigious Franchise Customer Experience Certification

Salon Today

The Franchise Customer Experience Certification is awarded to franchise brands that demonstrate superior practices leading to enhanced franchise profitability via exceptional franchisee and consumer experiences.

Salon 64
article thumbnail

Unmasking Botulinum Toxin Myths

Dermatology Times

Misleading marketing and incomplete scientific data have led to widespread misinformation about botulinum toxin products.

More Trending

article thumbnail

How the world’s biggest travel spenders define luxury

Spa Executive

Chinese women have been named the world’s biggest travel spenders and are playing an important role in shaping the world of travel, particularly luxury travel. Un Tourism recently reported that China had reclaimed its position as the top spender on international tourism, as the country’s expenditure on travel abroad reached USD 196.5 billion in 2023.

article thumbnail

Boost Energy with These 8 Protein-Rich Breakfast Ideas for Women Over 40

Alison Bladh

As women over 40, especially those navigating menopause, it’s essential to prioritise protein in our meals, particularly at breakfast. Starting your day with a protein-rich meal can have a significant impact on your energy levels, mental clarity, and overall wellbeing. In this blog, I’ll explore why a protein-rich breakfast is important and share 8 breakfast ideas to fuel your morning.

article thumbnail

April Armstrong, MD, MPH, Shares Insights on the NPF's Psoriasis Health Indicator Report

Dermatology Times

Armstrong shared insights on the recently released NPF psoriasis health indicator report including pearls on national health data and unmet needs in public health campaigns.

45
article thumbnail

NEA Study Seeks to Refine Definition of Eczema Flares: Here’s What They Found

The Dermatology Digest

What is an eczema flare? Flare is commonly used in eczema care and clinical research, but there’s been little agreement on what it means until now. The National Eczema Association conducted real-world research identifying patient-reported attributes associated with an atopic dermatitis (eczema) ‘flare’ to develop a patient-centered, consensus-based working definition of the term.

Eczema 36
article thumbnail

Definitions and Diagnostic Criteria of Generalized Pustular Psoriasis Require Continuity, Accuracy, Researchers Report

Dermatology Times

Researchers authored a manuscript detailing considerations for GPP diagnosis, definitions, and management.

article thumbnail

Image-Guided SRT Boasts Consistent High Freedom From Recurrence of Nonmelanoma Skin Cancer Regardless of Age or Sex

The Dermatology Digest

Image-guided superficial radiation therapy (IGSRT or Image-Guided SRT) keeps nonmelanoma skin cancer (NMSC) recurrences at bay, according to new research. For the large retrospective cohort study, researchers culled treatment records for nearly 20,000 NMSC lesions from 28 institutions in 12 states from 2016 to 2023. They found freedom from recurrence rates of 99.68% at two years, 99.57% at four years, and 99.57% at six years.

Surgery 36
article thumbnail

Comparing Devices to Assess Facial Pigmentary and Inflammatory Conditions

Dermatology Times

Precision measurements are necessary to improve the current therapeutic armamentarium in pigmentary disorders.

Facials 41